An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularensis

被引:62
作者
Jiang, Jian [2 ]
Parker, Carol E. [1 ]
Fuller, James R. [1 ]
Kawula, Thomas H. [3 ]
Borchers, Christoph H. [1 ]
机构
[1] UNC CH, Dept Biochem & Biophys, Chapel Hill, NC USA
[2] UNC CH, Curriculum Appl & Mat Sci, Chapel Hill, NC USA
[3] UNC CH, Dept Microbiol, Chapel Hill, NC USA
关键词
Francisella tularensis; immunoaffinity tandem mass spectrometry; matrix-assisted laser desorption/ionization; quantitation;
D O I
10.1016/j.aca.2007.10.025
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Francisella tularensis (F. tularensis) has been designated by the CDC as 1 of the 10 organisms most likely to be engineered for bioterrorism. Symptoms of tularemia in humans are nonspecific, thus making the disease difficult to diagnose. If not quickly diagnosed and treated, the disease has a high mortality rate - thus methods for early and specific diagnosis are of critical importance. This immunoaffinity MALDI MS/MS (iMALDI) assay provides unambiguous detection of F tularensis peptides at attomole levels from peptide solutions, and at low CFU levels from bacteria. The addition of stable-labeled versions of the peptide as internal standards allows absolute quantitation of F. tularensis peptides with a linear dynamic range spanning two orders of magnitude. The ability of mass spectrometry to obtain amino acid sequence data on affinity-captured peptides provides absolute specificity and avoids "false positives" from the non-specific binding. The F. tularensis iMALDI assay has been applied to different samples, such as nasal swabs. This novel quantitative diagnostic F. tularensis iMALDI assay allows the safe, sensitive, and specific detection of F. tularensis. The assay can be easily adapted to other target peptides and therefore has broad application potential in clinical diagnosis of other pathogens and diseases. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:70 / 79
页数:10
相关论文
共 55 条
[51]   Electrospray ionization tandem mass spectrometry of model peptides reveals diagnostic fragment ions for protein ubiquitination [J].
Warren, MRE ;
Parker, CE ;
Mocanu, V ;
Klapper, D ;
Borchers, CH .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2005, 19 (04) :429-437
[52]   Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry:: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures [J].
Wright, GL ;
Cazares, LH ;
Leung, SM ;
Nasim, S ;
Adam, BL ;
Yip, TT ;
Schellhammer, PF ;
Gong, L ;
Vlahou, A .
PROSTATE CANCER AND PROSTATIC DISEASES, 1999, 2 (5-6) :264-276
[53]   Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope [J].
Xu, W ;
Ellington, AD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7475-7480
[54]   PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings [J].
Yang, S ;
Rothman, RE .
LANCET INFECTIOUS DISEASES, 2004, 4 (06) :337-348
[55]   Detection of Francisella tularensis by the polymerase chain reaction [J].
Zhai, JH ;
Yang, RF ;
Lu, JC ;
Zhang, GL ;
Chen, ML ;
Che, FX ;
Hong, C .
JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 45 (06) :477-482